U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Famous Patents

The first match was accidentally discovered in 1826 when John Walker scraped a stick with chemicals on the end against a stone floor.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/680 - Polycyclo ring system


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter which contains a polycyclo ring system.
No. of patents: 134
Last issue date: 08/03/2010


1        
NumberTitleIssue Date
7767719Anthracenedione compounds
This invention relates compositions containing compounds of formula (I) below: Each of R1, R2, R3, R4, R5, R6, R7, and R8 is defined in t...
08/03/2010
77324932-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
The invention relates to new 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula I in which R2 means a C1-C8-alkyl group, a C1-C
06/08/2010
74357572-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
The invention relates to new 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula I in which R2 means a C1-C8-alkyl group, a C1-C
10/14/2008
7432284Estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v...
10/07/2008
7432303Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present inventi...
10/07/2008
7265248Compositions and methods for the treatment of malaria
A colchicine derivative and a method of using a colchicine derivative as a pharmacological agent in the treatment of malaria are provided. ...
09/04/2007
7238377Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity
The invention concerns the use of at least an oil derived from the seeds of the gourd family selected from the group consisting of Lagenaria, Luffa and Momordica, for preparing a composition designed to inhibit 5α-reductase activity, and the use of sa...
07/03/2007
7235392Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
Cell preparations comprising a plurality of apoptotic EBV-transformed B lymphocytes and methods of producing cell preparations comprising a plurality of apoptotic EBV-transformed B lymphocytes. The methods comprise transforming B lymphocytes with EBV, incubating the...
06/26/2007
7230139Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid...
06/12/2007
7217844Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid...
05/15/2007
7199159Use of biguanide derivatives for making a medicine having a wound healing effect
The present invention relates to the use of biguanide derivatives of general formula I below: in which: the groups R1 and R2 represent, independently of each other, a hydrogen a...
04/03/2007
7157477Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
The invention involves a methods and compositions for use in photodynamic therapy. Novel perylenequinone derivatives, conjugates comprising perylenequinone derivatives and a binding agent, and methods of treatment using these compositions are disclosed. The present ...
01/02/2007
7151196Estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v...
12/19/2006
7135502Colchinol derivatives as vascular damaging agents
The invention relates to the use of compounds of formula (I): wherein X is —C(O)—, —C(S)—, —C═NOH, or —CH(R7)— wherein R7 is hydrogen, hydroxy, C1-7alkoxy, —OR8 or —NR8R9 (wherein ...
11/14/2006
7122518Method for preventing or reducing collateral phototoxic damage to neighboring tissues during photodynamic therapy of a target tissue
A method is provided for preventing or reducing the adverse effects of photodynamic therapy such as collateral damage by regulating the localized phototoxicity of an effector photosensitizer molecule. During photodynamic therapy, the activity of the effector photose...
10/17/2006
7101917Mitochrondrial permeability transition pore affinity labels and modulators
Methods of utilizing compounds of general formulas I and II as modulators and affinity labels of the MPTP complex are elucidated. Furthermore, methods for modulating the activity of the MPTP complex, methods for determining the presence of a component of the MPTP co...
09/05/2006
7087599Estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v...
08/08/2006
RE39199Antipsoriatic compositions, method of making, and method of using
A psoriasis treatment composition derived from the plant Asphodelus Microcarpus includes 3-methylanthralin, chrysophanol, aloe-emodin, aloe-emodin monoacetate, and/or derivatives thereof. The composition is prepared by extracting a liquid from the Asphodelus Microca...
07/18/2006
7060686Anti-inflammatory compounds derived from
Methods for treating, preventing, or inhibiting diseases and disorders associated with inflammation, cell-proliferation, and pain comprising the administration of a compound having the structural formula wherein ...
06/13/2006
7001877Organic laundry detergent and method of producing the same
The present invention is a laundry detergent or powder and method of making the same utilizing natural components such as but not limited to milk, beeswax, sodium hydroxide or lye, vegetable or soy oil, sugar, baking soda, and corn starch. It is still further contem...
02/21/2006
6958159Pharmaceutical gel composition
The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin. ...
10/25/2005
6949250Selective algaecides for control of cyanochloronta
We have now discovered that certain 9,10-anthraquinone derivatives we developed possess potent activity against O. perornata while possessing a sufficiently high level of solubility in water to make their activity against O. perornata viable. These com...
09/27/2005
6949557Hydroanthracene based compounds as anticancer agents
The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of hy...
09/27/2005
6936571Fungicidal composition containing PQDs
The present invention provides an agricultural fungicidal composition containing active compounds selected from perylenequinonoid derivatives or salts thereof. The invention also relates the application of the composition against fungal plant infections. ...
08/30/2005
6906059Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances
The use of benzazepin-N-acetic acid derivatives which contain an oxo group in the a position to the nitrogen atom and are substituted in the 3 position by a 1-(carboxyalkyl)-cyclopentyl-carbonyl-amino radical, and of their salts and biolabile esters, for the prophyl...
06/14/2005
6903238Substituted indenones as estrogenic agents
This invention provides estrogen receptor modulators of formula I, having the structure R1, R2, and R3 are as defined in the specification, or a pharmaceutically acceptable salt thereof...
06/07/2005
6894073Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer
The disclosure concerns novel use of diterpene compound as a therapeutic agent of inlfammation, immune disease or cancer. More particularly, the present invention relates to novel use of diterpene compound that include kamebanin, kamebacetal A, kamebakaurin, and exi...
05/17/2005
6867235Helianthrone derivatives as anti-cancer agents
Hypericin, helianthrone and derivatives thereof of general formula (I) wherein the dotted line between positions 11 and 12 represent an optional C11-C12 bond; R is independently selected from the group consisting of hy...
03/15/2005
6812255Use of aloe-emodin in the treatment of neuroectodermal tumors
The invention relates to the use of anti-cancer drug of a natural compound of vegetal origin, known as aloe-emodin (AE). Indeed, said compound has proved to have a specific biological activity of inhibition on the growth of neuroectodermal tumors, without evident to...
11/02/2004
6790463Uses of targeted oxidative therapeutic formulation in arteriosclerosis
The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by a...
09/14/2004
6777447Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone, and therapeutic uses thereof
Benzylidene cyclohexanone, cyclopentanone and acteone derivatives and therapeutic methods of using same are disclosed. The compounds are non-toxic and exhibit potent anti-inflammatory, antibacterial and antioxidation activity. Also, certain compounds of the inventio...
08/17/2004
6773727Use of gossypol and related terpenes for control of urban and agricultural pests
Low concentrations of gossypol and related phyllophage toxins from cotton improve the effectiveness of insecticidal agents against social insects, including cockroaches, and particularly termites and ants. Levels of gossypol and other cotton phyllophage toxins which...
08/10/2004
6706767Therapeutics for chemokine mediated diseases
The invention provides therapeutic and biological uses of chemokine-receptor-binding compounds including uses in the treatment of disease states mediated by chemokines. The relevant chemokines may for example be monocyte chemoattractant protein-one (MCP-1) or interl...
03/16/2004
6696484Method and compositions for regulation of 5-alpha reductase activity
Pharmaceutical compositions and methods for treating androgen related disorders. The pharmaceutical compositions may include a 5଱-reductase inhibitor, such as natural and synthetic flavanoids, catechols, curcumin-related substances, quinones, catech...
02/24/2004
6686393Pharmaceutical compositions having antiviral activity against human cytomegalovirus
The present invention is directed to the use of antiviral compounds having the following generalized structure: ##STR1## wherein R is 2H or .dbd.O; R' is OH, H, or COOH (single substitution); and R" is OH, H, or alkyl; and pharmaceutically acceptable salt...
02/03/2004
6627664Perylenequinones for use as sonosensitizers
The invention is perylenequinones that are both sonosensitizers and photosensitizers, and their therapeutic use....
09/30/2003
6596774Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives
The present invention is the synthesis of a series of 1,5-dichloro-9(10H)-anthracenones bearing O-linked and N-linked substituents in the 10-position. These compounds were evaluated for their ability to inhibit the growth of the human oral epidermoid carc...
07/22/2003
6586419Phototherapeutic inactivation of ocular viruses
A method for inactivating ocular viral pathogens and for treating associated lesions on tissue by means of selectively activating a tissue-associated photosensitizing agent with light. The photosensitizing agent, preferably tin ethyl etiopurpurin, is admi...
07/01/2003
6576674Method of controlling zoological and aquatic plant growth
A method of controlling target aquatic microorganism pest populations by exposing the target population to a toxic amount of an aquacidal compound comprising an anthraquinone. The method is particularly effective for treating ballast water of ships or oth...
06/10/2003
6576660Methods and compositions for regulation of 5-଱-reductase activity
Compounds that inhibit 5-alpha-reductase are provided. The compounds are used to treat prostate cancer, breast cancer, obesity, skin disorders and baldness....
06/10/2003
1        
 
Sign InRegister
Username  
Password   
forgot password?